Seaport Therapeutics
Latest round
- Series B
Last raised
- Oct 2024
Total raised
- $326M
Investors
- 10
About Seaport Therapeutics
Based in Massachusetts, US, and founded in 2024 by co-founders Steven Paul and Daphne Zohar, Seaport Therapeutics, Inc. operates as a healthtech-based company providing biotherapeutics clinical-stage to develop neuropsychiatric medicines.P.5% stake in Seaport Therapeutics, Inc. common stock. The firm trades on the Nasdaq Global Select Market under the ticker symbol "SPTX" Seaport Therapeutics, Inc. Seaport Therapeutics, Inc. developed a Glyph technology platform, which is designed to enable oral bioavailability, bypass first-pass metabolism, and mitigate hepatotoxicity and other adverse effects associated with traditional medications in this space. The company offers expertise with solutions to patients living with conditions such as major depression with anxiety, generalized anxiety disorder, and other mood and neuropsychiatric disorders. In addition, the firm offers various programs such as SPT-300 (Glyph Allopregnanolone), SPT-320 (Glyph Agomelatine), and SPT-348 (non-hallucinogenic neuroplastogen).
Who invested in Seaport Therapeutics
10 investors across 2 rounds
See all investors in Seaport Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Seaport Therapeutics
Who invested in Seaport Therapeutics?
Seaport Therapeutics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Seaport Therapeutics raised?
Seaport Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Seaport Therapeutics last raise money?
Seaport Therapeutics's most recent round on record is a Series B, in Oct 2024.
What does Seaport Therapeutics do?
Based in Massachusetts, US, and founded in 2024 by co-founders Steven Paul and Daphne Zohar, Seaport Therapeutics, Inc.
Where is Seaport Therapeutics headquartered?
Seaport Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Seaport Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Seaport Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Seaport Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.